Brotchie JM - Search Results

1

Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomes.

East SJ, Hill MP, Brotchie JM. East SJ, et al. Among authors: brotchie jm. Eur J Pharmacol. 1995 Apr 13;277(1):117-21. doi: 10.1016/0014-2999(95)00119-6. Eur J Pharmacol. 1995. PMID: 7635167

2

Modulation of glutamate release by a kappa-opioid receptor agonist in rodent and primate striatum.

Hill MP, Brotchie JM. Hill MP, et al. Among authors: brotchie jm. Eur J Pharmacol. 1995 Jul 25;281(1):R1-R2. doi: 10.1016/0014-2999(95)00385-x. Eur J Pharmacol. 1995. PMID: 8566106

3

Control of glutamate release by calcium channels and kappa-opioid receptors in rodent and primate striatum.

Hill MP, Brotchie JM. Hill MP, et al. Among authors: brotchie jm. Br J Pharmacol. 1999 May;127(1):275-83. doi: 10.1038/sj.bjp.0702523. Br J Pharmacol. 1999. PMID: 10369483 Free PMC article.

4

The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat.

Hill MP, Brotchie JM. Hill MP, et al. Among authors: brotchie jm. Br J Pharmacol. 1999 Dec;128(7):1577-85. doi: 10.1038/sj.bjp.0702943. Br J Pharmacol. 1999. PMID: 10602339 Free PMC article.

5

Ionotropic glutamate receptors and nitric oxide synthesis in the rat striatum.

East SJ, Parry-Jones A, Brotchie JM. East SJ, et al. Among authors: brotchie jm. Neuroreport. 1996 Dec 20;8(1):71-5. doi: 10.1097/00001756-199612200-00015. Neuroreport. 1996. PMID: 9051755

6

Kappa-opioid receptor agonists increase locomotor activity in the monoamine-depleted rat model of parkinsonism.

Hughes NR, McKnight AT, Woodruff GN, Hill MP, Crossman AR, Brotchie JM. Hughes NR, et al. Among authors: brotchie jm. Mov Disord. 1998 Mar;13(2):228-33. doi: 10.1002/mds.870130206. Mov Disord. 1998. PMID: 9539334

7

Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat.

Nash JE, Hill MP, Brotchie JM. Nash JE, et al. Among authors: brotchie jm. Exp Neurol. 1999 Jan;155(1):42-8. doi: 10.1006/exnr.1998.6963. Exp Neurol. 1999. PMID: 9918703

8

Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease.

Di Marzo V, Hill MP, Bisogno T, Crossman AR, Brotchie JM. Di Marzo V, et al. Among authors: brotchie jm. FASEB J. 2000 Jul;14(10):1432-8. doi: 10.1096/fj.14.10.1432. FASEB J. 2000. PMID: 10877836

9

Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease.

Nash JE, Fox SH, Henry B, Hill MP, Peggs D, McGuire S, Maneuf Y, Hille C, Brotchie JM, Crossman AR. Nash JE, et al. Among authors: brotchie jm. Exp Neurol. 2000 Sep;165(1):136-42. doi: 10.1006/exnr.2000.7444. Exp Neurol. 2000. PMID: 10964492

10

Delta-opioid receptor agonists as a therapeutic approach in Parkinson's disease.

Hill MP, Hille CJ, Brotchie JM. Hill MP, et al. Among authors: brotchie jm. Drug News Perspect. 2000 Jun;13(5):261-8. Drug News Perspect. 2000. PMID: 12937640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters